Disruptive Innovations in Genomics (DIG) Phase 2 Funding Competition


Genome Canada



This competition is closed. All submitted proposals will be assessed according to the process outlined in the competition timeline, and results will be announced as indicated.

Ontario Genomics, the future is in our genes banner with dna imagery

On July 26, 2017 Genome Canada launched a Request for Applications (RFA) seeking proposals for research projects which focus on Disruptive Innovations in Genomics.

For the purposes of this competition, a Disruptive Innovation must be either a new genomics technology or the application of an existing technology from another field, applied to the field of genomics. The Innovation must be truly transformative in that it has the potential to either displace an existing technology, disrupt an existing market or create a new market. A Disruptive Innovation offers the capability to do things not previously possible and is not an incremental improvement of an existing technology.

This is a cloased competition open only to eligible projects funded through the previous DIG Phase 1 competition. The Phase 2 competition aims to support projects focused on prototype development. The timeline below for Phase 2 funding will allow eligible projects to continue to Phase 2 without a gap in funding, and for projects not approved for Phase 2 funding to wind down.

All applicants must demonstrate, with supporting evidence, the potential for the innovation to be disruptive, have impact within the technology space, and eventually benefits to Canada. In addition, Phase 2 projects must have clear deliverables that will be realized by the end of the project and a plan which explains the next steps of how the deliverables from the research will be transferred, disseminated, used, and/or applied to realize the benefits.

In order to better prepare Ontario-led projects for this competition, OGI will do an initial eligibility assessment of registrations and will coordinate an external review of eligible applications prior to submission to Genome Canada. Please note that to accommodate this process the deadlines for submission to OGI differ from those in the official RFA from Genome Canada. Eligible applicants will receive feedback on their applications including gaps and areas for improvement.

Researchers in Ontario intending to submit an application are strongly encouraged to contact OGI to discuss details of the competition such as the scope, the application process, and co-funding requirements.

Funding Available

There is approximately $5.5 million available for this competition from Genome Canada. Please see the table below for the funding breakdown and co-funding requirements:

Phase 2
Genome Canada Funding Available Approx. $5.5M
Co-funding At least two thirds of project budget
Genome Canada Investment per Project (Maximum) $1M
Term of Project (Maximum) Three years


Info at Ontario Genomics

Key Dates

Draft Registrations due to OG (signatures not required)

October 10, 2017

Final Registrations due to OG

October 24, 2017

Final Registrations due to Genome Canada

October 26, 2017

Draft Applications due to OG

December 4, 2017

Final Applications due to OG

February 8, 2018

Final Applications due to Genome Canada

February 15, 2018

Shortlisted applicants notified regarding interviews with reviewers

April, 2018

Review committee meeting, including interviews with applicants

May, 2018

Decisions by Genome Canada

June, 2018

Notification of Decision

Late June, 2018